gatifloxacin has been researched along with Angina at Rest in 4 studies
Gatifloxacin: A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS.
gatifloxacin : A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cannon, CP | 3 |
| Braunwald, E | 3 |
| McCabe, CH | 2 |
| Grayston, JT | 1 |
| Muhlestein, B | 1 |
| Giugliano, RP | 1 |
| Cairns, R | 2 |
| Skene, AM | 1 |
| Anderson, JL | 1 |
| Mega, JL | 1 |
| Morrow, DA | 1 |
| Murphy, S | 1 |
| Ridker, PM | 1 |
| Belder, R | 1 |
| Breen, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| [NCT00000617] | Phase 3 | 0 participants | Interventional | 1998-09-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for gatifloxacin and Angina at Rest
| Article | Year |
|---|---|
Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome.
Topics: Aged; Angina, Unstable; Anti-Bacterial Agents; Cardiovascular Diseases; Chlamydophila Infections; Ch | 2005 |
Cholesterol, C-reactive protein, and cerebrovascular events following intensive and moderate statin therapy.
Topics: Aged; Angina, Unstable; Atorvastatin; C-Reactive Protein; Cholesterol; Epidemiologic Methods; Female | 2006 |
2 other studies available for gatifloxacin and Angina at Rest
| Article | Year |
|---|---|
Infection, antibiotics, and atherothrombosis--end of the road or new beginnings?
Topics: Angina, Unstable; Anti-Bacterial Agents; Azithromycin; Cardiovascular Diseases; Chlamydophila Infect | 2005 |
Design of the Pravastatin or Atorvastatin Evaluation and Infection Therapy (PROVE IT)-TIMI 22 trial.
Topics: Angina, Unstable; Anti-Infective Agents; Anticholesteremic Agents; Atorvastatin; Chlamydophila Infec | 2002 |